Referred to the House Committee on Energy and Commerce.
The bill codifies the Advisory Committee on Immunization Practices (ACIP) into the Public Health Service Act, specifying its duties, membership, meeting rules, evidence standards, public reporting, and timelines for considering newly licensed vaccines. It requires the HHS Director to adopt ACIP recommendations unless they are not supported by a preponderance of the best available, peer-reviewed scientific evidence, with publication and 48-hour congressional notification if recommendations are not adopted.
Liberals highlight scientific independence and transparency gains
Relative to its intended legislative type, this bill is a well-specified administrative/operational statute that codifies the Advisory Committee on Immunization Practices, defines duties and processes, integrates with existing law, and authorizes modest funding.
The bill codifies the Advisory Committee on Immunization Practices (ACIP) into the Public Health Service Act, specifying its duties, membership, meeting rules, evidence standards, public reporting, and timelines for considering newly licensed vaccines.
It requires the HHS Director to adopt ACIP recommendations unless they are not supported by a preponderance of the best available, peer-reviewed scientific evidence, with publication and 48-hour congressional notification if recommendations are not adopted.
The bill defines required expertise and stakeholder organizations, authorizes $2.8 million annually for fiscal years 2026–2029, and amends the National Vaccine Injury Compensation Program to require that removals or other modifications to the Vaccine Injury Table be supported by a preponderance of the best available scientific evidence.
Modest cost and technical framing help, but political sensitivity of vaccine oversight and added congressional triggers reduce probability.
Relative to its intended legislative type, this bill is a well-specified administrative/operational statute that codifies the Advisory Committee on Immunization Practices, defines duties and processes, integrates with existing law, and authorizes modest funding. It also contains a substantive change to the National Vaccine Injury Compensation Program evidentiary standard for removal/modification of entries.
Liberals highlight scientific independence and transparency gains
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals highlight scientific independence and transparency gains
Likely broadly supportive because the bill locks ACIP's role and requires evidence-based recommendations, transparency, and timely vaccine review.
Concerned about potential industry influence from listed stakeholder organizations and the need for strong conflict-of-interest safeguards.
Views NVICP amendment as a science-based protection against arbitrary changes, though practical effects are somewhat uncertain.
Generally positive about codifying ACIP for predictable, transparent vaccine policy, but cautious about new procedural burdens and possible politicization.
Sees merit in congressional reporting and timelines, while wanting clear operational guidance and adequate funding.
Will weigh tradeoffs between independence and executive flexibility.
Mixed to somewhat opposed.
Supports transparency and an evidence standard, but worries the bill constrains executive authority, increases federal control over insurance coverage of vaccines, and creates new bureaucracy.
Concerned about mandated insurer coverage link and annual appropriations.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest cost and technical framing help, but political sensitivity of vaccine oversight and added congressional triggers reduce probability.
The bill has not accumulated any surfaced votes yet.
Liberals highlight scientific independence and transparency gains
Modest cost and technical framing help, but political sensitivity of vaccine oversight and added congressional triggers reduce probability.
Relative to its intended legislative type, this bill is a well-specified administrative/operational statute that codifies the Advisory Committee on Immunization Practices, defines duties and processes, integrates with e…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.